Sirolimus encapsulated liposomes for cancer therapy: Physicochemical and mechanical characterization of sirolimus distribution within liposome bilayers

Molecular Pharmaceutics

Volumn 10, Issue 11, 2013, Pages 4281-4293

  Onyesom, Ichioma ^a   Lamprou, Dimitrios A ^b   Sygellou, Lamprini ^c   Owusu Ware, Samuel K ^a   Antonijevic, Milan ^a   Chowdhry, Babur Z ^a   Douroumis, Dennis ^a  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c INSTITUTE OF CHEMICAL ENGINEERING SCIENCES   (Greece)

Author keywords

atomic force microscopy; mechanical properties; sirolimus; stealth liposomes; X ray photon electron analysis

Indexed keywords

CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLCHOLINE; LIPOSOME; NANOPARTICLE; RAPAMYCIN;

ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER THERAPY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DISTRIBUTION; HUMAN; LIPID BILAYER; MEMBRANE PERMEABILITY; NANOENCAPSULATION; PARTICLE SIZE; PHOSPHOLIPID BILAYER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING PROBE MICROSCOPY; X RAY PHOTOELECTRON SPECTROSCOPY; YOUNG MODULUS; ZETA POTENTIAL;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; CALORIMETRY, DIFFERENTIAL SCANNING; LIPOSOMES; MICROSCOPY, ATOMIC FORCE; SIROLIMUS;

EID: 84887372251     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400362v     Document Type: Article

References (43)

1. Saunders, R. N.; Metcalfe, M. S.; Nicholson, M. L. Rapamycin in transplantation: a review of the evidence Kidney Int. 2001, 59, 3-16
2. Sousa, J. E.; Costa, M. A.; Abizaid, A. C. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up Circulation 2001, 104, 2007-11
3. Bjornsti, M. A.; Houghton, P. J. The TOR pathway: a target for cancer therapy Nat. Rev. Cancer 2004, 4, 335-48
4. Tibbetts, R. S.; Abraham, R. T. PI3K-related kinases-roles in cell-cycle regulation and DNA damage responses. In Signaling networks and cell cycle control: the molecular basis of cancer and other diseases; Humana Press: Bethesda, MD, 2000; pp 267-301.
5. Chen, J.; Fang, Y. A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling Biochem. Pharmacol. 2002, 64, 1071-7
6. Mita, M. M.; Mita, A.; Rowinsky, E. K. The molecular target of rapamycin (mTOR) as a therapeutic target against cancer Cancer Biol. Ther. 2003, 2, S169-77
7. Edinger, A. L.; Linardic, C. M.; Chiang, G. G.; Thompson, C. B.; Abraham, R. T. Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells Cancer Res. 2003, 63, 8451-60
8. Liu, M.; Howes, A.; Lesperance, J.; Stallcup, W. B.; Hauser, C. A.; Kadoya, K.; Oshima, R. G.; Abraham, R. T. Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer Cancer Res. 2005, 65 (12) 5325-36
9. Lian, T.; Ho, R. J. Trends and developments in liposome drug delivery systems J. Pharm. Sci. 2001, 90 (6) 667-80
10. Storm, G.; Crommelin, D. Liposomes: quo vadis? Pharm. Sci. Technol. Today 1998, 1, 19-31
11. Immordino, M. L.; Dosio, F.; Cattel, L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomed. 2006, 1 (3) 297-315
12. Reddy, K. R. Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs Ann. Pharmacother. 2000, 34 (7-8) 915-23
13. Bakker-Woudenberg, I. A.; Storm, G.; Woodle, M. C. Liposomes in the treatment of infections J. Drug Targeting 1994, 2, 363-71
14. Gabizon, A.; Martin, F. Polyethylene glycol-coated (pegylated) liposomal doxorubicin Drugs 1997, 54 (Suppl. 4) 15-21
15. Rouf, M. A.; Vural, I.; Renoir, J. M.; Hincal, A. A. Development and characterization of liposomal formulations for rapamycin delivery and investigation of their antiproliferative effect on MCF7 cells J. Liposome Res. 2009, 19 (4) 322-31
16. Elbayoumi, T. A.; Torchilin, V. P. Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice Mol. Pharmaceutics 2009, 6 (1) 246-54
17. 1H NMR Detection of Mobile Lipids as a Marker for Apoptosis: The Case of Anticancer Drug-Loaded Liposomes and Polymeric Micelles Mol. Pharmaceutics 2009, 6 (6) 1876-1882
18. Castelli, F.; Sarpietro, M. G.; Ceruti, M.; Rocco, F.; Cattel, L. Characterization of lipophilic gemcitabine prodrug-liposomal membrane interaction by differential scanning calorimetry Mol. Pharmaceutics 2006, 3 (6) 737-44
19. Zeng, Q.; Yang, Z.; Gao, Y. J.; Yuan, H.; Cui, K.; Shi, Y.; Wang, H.; Huang, X.; Wong, S. T.; Wang, Y.; Kesari, S.; Ji, R. R.; Xu, X. Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: an in vivo bioluminescence imaging study Eur. J. Cancer 2010, 46 (6) 1132-43
20. Ramachandran, S.; Quist, A. P.; Kumar, S.; Lal, R. Cisplatin nanoliposomes for cancer therapy: AFM and fluorescence imaging of cisplatin encapsulation, stability, cellular uptake, and toxicity Langmuir 2006, 22 (19) 8156-62
21. Zhao, L. Y.; Feng, S. S. Effects of cholesterol component on molec- ular interactions between paclitaxel and phospholipid within the lipid monolayer at the air-water interface J. Colloid Interface Sci. 2006, 300, 314-326
22. Bangham, A. D.; Standish, M. M.; Watkins, J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 1965, 13, 238-252
23. Souza, E. F.; Teschke, O. Liposome stability verification by atomic force microscopy Rev. Adv. Mater. Sci. 2003, 5 (1) 34-40
24. Castelli, F.; Raudino, A.; Fresta, M. J. A mechanistic study of the permeation kinetics through biomembrane models: Gemcitabine-phospholipid bilayer interaction J. Colloid Interface Sci. 2005, 285, 110-117
25. Rouf, M. A.; Vural, I.; Renoir, J. M.; Hincal, A. A. Development and characterization of liposomal formulations for rapamycin delivery and investigation of their antiproliferative effect on MCF7 cells J. Liposome Res. 2009, 19 (4) 322-31
26. Benachir, T.; Lafleur, M. Osmotic and pH transmembrane gradients control the lytic power of melittin Biophys. J. 1996, 70 (2) 831-40
27. Gubernator, J.; Stasiuk, M.; Kozubek, A. Dual effect of alkylresorcinols, natural amphiphilic compounds, upon liposomal permeability Biochim. Biophys. Acta 1999, 1418 (2) 253-60
28. Piperoudi, S.; Fatouros, D.; Ioannou, P. V.; Frederik, P.; Antimisiaris, S. G. Incorporation of PEG-lipids in arsonoliposomes results in formation of highly stable arsenic-containing vesicles Chem. Phys. Lipids 2006, 139 (2) 96-106
29. Shimanouchi, T.; Ishii, H.; Yoshimoto, N.; Umakoshi, H.; Kuboi, R. Calcein permeation across phosphatidylcholine bilayer membrane: Effects of membrane fluidity, liposome size, and immobilization Colloids Surf., B 2009, 73, 156
30. Lamprou, D. A.; Venkatpurwar, V.; Ravi Kumar, M. N. V. Atomic force microscopy images label-free, drug encapsulated nanoparticles in vivo and detects difference in tissue mechanical properties of treated and untreated: a tip for nanotoxicology PloS One 2013, 8, e64490
31. Jung, H.; Kim, J.; Park, J. W.; Lee, S. E.; Lee, H. Y.; Kuboi, R.; Kawai, T. Atomic force microscopy observation of highly arrayed phospholipid bilayer vesicle on a gold surface J. Biosci. Bioeng. 2006, 102, 28
32. Tarasova, A.; Griesser, H. J.; Meagher, L. AFM study of the stability of a dense affinity-bound liposome layer Langmuir 2008, 24, 7371
33. Serro, A. P.; Carapeto, A.; Paiva, G.; Farinha, J. P. S.; Colaço, R.; Saramago, B. Formation of an intact liposome layer adsorbed on oxidized gold confirmed by three complementary techniques: QCM-D, AFM and Confocal fluorescence microscopy Surf. Interface Anal. 2012, 44, 426
34. Crowe, J. H.; Hoekstra, F. A.; K. Nguyen, K. H. N.; Crowe, L. M. Is vitrification involved in depression of the phase transition temperature in dry phospholipids? Biochim. Biophys. Acta 1996, 1280, 187
35. Ohtake, S.; Schebor, C.; De Pablo, J. J. Effects of trehalose on the phase behavior of DPPC-cholesterol unilamellar vesicles Biochim. Biophys. Acta 2006, 1758, 65
36. Ohtake, S.; Schebor, C.; Palecek, S. P.; De Pablo, J. J. Phase behavior of freeze-dried phospholipid-cholesterol mixtures stabilized with trehalose Biochim. Biophys. Acta 2005, 1713, 57
37. Chen, C.; Han, D. C. C.; Tang, X. An overview of liposome lyophilization and its future potential J. Controlled Release 2010, 142, 299
38. Taylor, G. M. K.; Craig, D. Q. M. In Liposomes: A Practical Approach; Torchilin, V.; Weissig, V., Eds.; Oxford University Press: Oxford, 2003; Chapter 3, pp 92-99.
39. Papahadjopoulos, D.; Mocarello, M.; Eylar, H.; Isaac, T. Effects of proteins on thermotropic phase transitions of phospholipid membranes Biochim. Biophys. Acta 1975, 401, 317
40. Tabbakhian, M.; Rogers, J. A. Interaction of insulin, cholesterol-derivatized mannan, and carboxymethyl chitin with liposomes: A differential scanning calorimetry study Res. Pharm Sci. 2012, 7, 43
41. Hofmann, S. In Auger-and X-ray Photoelectron Spectroscopy in Material Science: A User Oriented Guide; Hofmann, S., Ed.; Springer: 2013; Chapter 7, pp 297-314.
42. Eighmy, T. T.; Kinner, A. E.; Shaw, E. L.; Eusden, J. D.; Francis, C. A. Surf. Sci. Spectra 1993, 6, 193
43. Kumar, S. N.; Bouyssoux, G.; Gaillard, F. Electronic and structural characterization of electrochemically synthesized conducting polyaniline from XPS studies Surf. Interface Anal. 1990, 15, 531